Cysvax

Diphtheria, Tetanus, Pertussis (Whole Cell), Hepatitis B (rDNA) and Haemophilus influenzae Type b Conjugate Vaccine (Adsorbed) 

A dark brown injectable solution containing B complex, Vitamins, Liver Extract and Choline Chloride. It is primarily used as supportive therapy in conditions leading to liver Dysfunction viz. liver fluke infestation, fatty degeneration of liver, in the treatment of anorexia and B complex Vitamin deficiency...

Light yellow flakes containing live Brucella abortus strain 19 bacteria in freeze driedpowder. Each dose contains not less than 40 x 10 9 organisms

Brucella Melitensis (strain rev-1) vaccine, living composition: Each dose contains Brucella melitensis strain rev.1 not less than 0.5X109 and not more than 4 X109 live bacteria, sucrose, enzymatic casein hydrolysate and sodium glutamate added as stabilizers. sterile diluent composition: disodium hydrogen...

Buparvaqone is a effective formulation used against Theileriosis and other theileriosis species.

combined clostridium perfringens and tetanus vaccine, inactivated composition: Each dose of 2mL contains: clostridium perfringens antigen type D ≥ 5 IU, tetanus toxoid antigen ≥ 2.5 units, thiomersal B.P ≤ 0.02% w/v as preservative, 2% w/v aluminium hydroxide gel ≤ 0.3mL and 0.85% w/v saline q.s

Brand name is Gyroflox. It is used in the treatment of diseases associated with bacteria susceptible to enrofloxacin.

Brand name is Gyroflox. It is used in the treatment of diseases associated with bacteria susceptible to enrofloxacin.

Fenbendazole bolus

Fenbendazole bolus

composition: FMD antigen serotype -A, thiomersal ≤ 0.01% w/v added as preservative, adult bovine serum 0.5% added as an stabilizer and virus maintenance medium Q.s

Indian Immunologicals Limited, in collaboaration with Griffith University, Australia is going to commence research for developing a vaccine for Corona virus, the pandemic which has infected more than two million and killed about 250,00 people across the world. 

Even WHO has considered the same in its latest draft landscape of COVID 19 vaccine candidates dated 30th April, 2020.